+ All Categories
Home > Documents > Distribution, OTC & CRAMS

Distribution, OTC & CRAMS

Date post: 31-Dec-2015
Category:
Upload: isaac-solomon
View: 40 times
Download: 1 times
Share this document with a friend
Description:
Distribution, OTC & CRAMS. Chesapeake Dr. Brian W Tempest www.briantempest.com [email protected] UK March 2014. 9. Pharma Distribution. Global US Distributors of Pharma Source: FT March 19 2013. - PowerPoint PPT Presentation
21
Hale & Tempest Distribution, OTC & CRAMS Chesapeake Dr. Brian W Tempest www.briantempest.com [email protected] UK March 2014
Transcript

Hale & Tempest

Distribution, OTC & CRAMS

Chesapeake

Dr. Brian W Tempest

www.briantempest.com

[email protected]

UK

March 2014

Hale & Tempest

9. Pharma Distribution

Hale & Tempest

Global US Distributors of PharmaSource: FT March 19 2013

•Walgreens has 45% of Alliance Boots with the option to buy the rest in 2 years

•Walgreens and Boots jointly buy 23% of Amerisource Bergen

• Boots Alliance owns 12% of Nanjing which is the 5th largest wholesaler in China & 50% of Guangzhou Pharmaceuticals which is ranked 6th wholesaler

•McKesson buys 50.1% of Celesio (including Lloyds)

•What will Cardinal/Kinray and Phoenix do?

Hale & Tempest

China Leading Distributor FosunPharma/Sinopharm

Hale & Tempest

Shanghai Pharma focussed on Expanding Distribution Across China source: Jefferies March 17 2014

Hale & Tempest

Russia - Complex Distribution source IMS

Hale & Tempest

Russia - Distributorssource: IMS

Hale & Tempest

Russia - Protek already has 158 productssource: CPhI Russia 17 April 2014

Hale & Tempest

Boots AllianceNumber of Almus Suppliers

Hale & Tempest

10. Over the Counter

Consumer Medicines (OTC)

Hale & Tempest

USA - OTC Switches from POMsource: FDA 102 switches from September 1976 to October 2013

Hale & Tempest

Europe - OTC Switches from POMsource: IMS 2013 8 out of top 20 EU Brands

Hale & Tempest

EE Pharmacy Turnover OTC vs Rx

source: james Dudley Management

Hale & Tempest

11. Contract Research &

Manufacturing (CRAMS)

Hale & Tempest

Contract Manufacturing & Contract Research Organisations Source: CPA Italy

•CMO & CROs $72b (2012) to $136b (2017) growing at 13% CGR

•CMO $47b (2012) to $93b(2017) - APIs & DFs, 2/3 toll manufacture & 1/3 custom synthesis

•CRO $25b (2012) to $43b (2017) growing at 11% CGR

•2012 % market share to 2017 % market share USA 34% to 25% EU 25% to 17% India 8% to 21% China 12% to 19% ROW 21% to 18%

Hale & Tempest

Indian CRAMs Source: Religare

Hale & Tempest

India Contract Manufacturers

Hale & Tempest

Indian Pharma in CRAMS

Source: Citi Research August 2013

Hale & Tempest

CPhI 2014

Hale & Tempest

CPhI Russia 137 Companies Source: 17 April 2014

•China 67•Russia 21•India 12•Italy 7•Czech Republic 5•Poland, Germany, South Korea 4•Indonesia, Pakistan, Romania, Latvia, Slovakia, Morocco, Jordan, Malaysia, , Spain, Greece, Ukraine, France Switzerland 1

Hale & Tempest

Thank [email protected]

www.briantempest.com


Recommended